A Study to Evaluate Abicipar Pegol for Safety and Treatment Effect in Participants With Neovascular Age-related Macular Degeneration (AMD)

PHASE2CompletedINTERVENTIONAL
Enrollment

124

Participants

Timeline

Start Date

May 25, 2018

Primary Completion Date

February 27, 2019

Study Completion Date

February 27, 2019

Conditions
Macular Degeneration
Interventions
DRUG

Abicipar pegol

Abicipar pegol 2 mg administered to the study eye by intravitreal injection on Day 1 and Weeks 4, 8, 16, and 24.

Trial Locations (37)

11580

Ophthalmic Consultants of Long Island, Lynbrook

12206

Capital Region Retina, PLLC, Albany

13224

Retina Vitreous Surgeons of Central NY, P.C., Syracuse

14620

Retina Associates of Western New York, Rochester

17011

Pennsylvania Retina Specialists, P.C., Camp Hill

23235

Retina Institute of Virginia, Richmond

29456

Charleston Neuroscience Institute, Ladson

30060

Georgia Retina, P.C., Marietta

Marietta Eye Clinic, Marietta

32503

Retina Specialty Institute, Pensacola

33711

Retina Vitreous Associates of Florida, St. Petersburg

33880

Center for Retina and Macular Disease, Winter Haven

45242

Cincinnati Eye Institute, Cincinnati

46290

Raj K. Maturi, MD, PC, Indianapolis

57701

Black Hills Regional Eye Institute, Rapid City

61704

Gailey Eye Clinic, Bloomington

66211

Sabates Eye Center, Leawood

76012

Texas Retina Associates, Arlington

76087

Strategic Clinical Research Group, LLC, Willow Park

77030

Retinal Consultants of Houston, Houston

77384

Retina Consultants of Houston, The Woodlands

78240

Retinal Consultants of San Antonio, San Antonio

78705

Austin Retina Associates, Austin

78731

Texan Eye, Austin

79606

Retina Research Institute of Texas, Abilene

79706

Premiere Retina Specialists, Midland

80401

Colorado Retina Associates, Golden

85016

Barnet Dulaney Perkins Eye Center, Phoenix

85710

Retina Associates Southwest, PC, Tucson

89502

Sierra Eye Associates, Reno

91006

Win Retina, Arcadia

91107

California Eye Specialists Medical Group, Inc, Pasadena

91741

Mark B. Kislinger, MD, Inc., Glendora

92647

Atlantis Retina Institute (Atlantis Eyecare), Huntington Beach

92835

Retina Consultants of Orange County, Fullerton

94040

N. California Retina Vitreous Associates Medical Group, INC., Mountain View

95819

Retinal Consultants Medical Group, Inc., Sacramento

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Allergan

INDUSTRY

NCT03539549 - A Study to Evaluate Abicipar Pegol for Safety and Treatment Effect in Participants With Neovascular Age-related Macular Degeneration (AMD) | Biotech Hunter | Biotech Hunter